Issues

Regulatory Issues

Developing a comprehensive approach to diagnostic reform – one that fosters innovative care delivery – is vital to our ability to tackle the most challenging and complex health needs of the country. Meaningful reforms must balance federal oversight with support for cutting-edge innovations and should account for distinct differences between laboratory developed tests (LDTs) and in vitro diagnostics (IVDs).

Related News

    Stay Informed Sign up for email updates on news and issues affecting the clinical laboratory industry. Join the Mailing List